HYDROXYLATION OF BENZPHETAMINE AND OTHER DRUGS BY A SOLUBILIZED FORM OF CYTOCHROME P-450 FROM LIVER MICROSOMES - LIPID REQUIREMENT FOR DRUG DEMETHYLATION

被引:150
作者
LU, AYH
STROBEL, HW
COON, MJ
机构
[1] Department of Biological Chemistry The University of Michigan, Ann Arbor, MI
关键词
D O I
10.1016/0006-291X(69)90339-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A solubilized hepatic microsomal enzyme system previously shown to catalyze the ω-hydroxylation of fatty acids also catalyzes the hydroxylation of drugs. Benzphetamine, aminopyrine, ethylmorphine, hexobarbital, norcodeine, and p-nitroanisole undergo aerobic demethylation in the presence of NADPH and the resolved enzyme system. The required submicrosomal components for benzphetamine demethylation, as determined either by formaldehyde liberation or by NADPH oxidation, are cytochrome P-450, NADPH-cytochrome P-450 reductase, and a heat-stable lipid fraction. Similar requirements were shown for the oxidation of aminopyrine, ethylmorphine, and hexobarbital. Laurate and benzphetamine were found to be mutually inhibitory, as would be expected if a common methyl hydroxylase" were involved. The solubilized cytochrome P-450 preparation exhibits a difference spectrum in the presence of benzphetamine with a peak at 392 mμ and a trough at 427 mμ and difference spectra with aniline and hexobarbital typical of those obtained with the microsomal bound form of this hemoprotein. © 1969."
引用
收藏
页码:545 / &
相关论文
共 29 条
[1]  
COCHIN J, 1959, J PHARMACOL EXP THER, V125, P105
[2]  
CONNEY AH, 1967, PHARMACOL REV, V19, P317
[3]  
CONNEY DY, 1968, J BIOL CHEM, V243, P3912
[4]  
COON MJ, 1969, MICROSOMES DRUG OXID, P151
[5]   PHOTOCHEMICAL ACTION SPECTRUM OF TERMINAL OXIDASE OF MIXED FUNCTION OXIDASE SYSTEMS [J].
COOPER, DY ;
LEVIN, S ;
NARASIMHULU, S ;
ROSENTHAL, O ;
ESTABROOK, RW .
SCIENCE, 1965, 147 (3656) :400-+
[6]   ON FATTY ACID AND HYDROCARBON HYDROXYLATION IN RAT LIVER MICROSOMES [J].
DAS, ML ;
ORRENIUS, S ;
ERNSTER, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1968, 4 (04) :519-&
[7]  
ESTABROOK RW, 1963, BIOCHEM Z, V338, P741
[8]  
ESTABROOK RW, 1967, CHEMICAL BIOLOGICAL, P153
[9]  
GEORGE WJ, 1968, MOL PHARMACOL, V4, P502
[10]  
Gillette J R, 1966, Adv Pharmacol, V4, P219, DOI 10.1016/S1054-3589(08)60100-3